Lozivate-MF XL Ointment
Marketer
Canixa Life Sciences Pvt Ltd
Salt Composition
Clobetasol (0.05% w/w) + Salicylic Acid (3% w/v) + Lactic Acid (3% w/w) + Urea (10% w/w)
Overview Lozivate-MF XL Ointment
Eczema and psoriasis are effectively managed with the prescription topical combination therapy, Lozivate-MF XL Ointment. This ointment alleviates symptoms such as redness, itching, and swelling by removing dead skin cells and promoting skin softening. Always adhere to your doctor's prescribed dosage and duration. Wash your hands before application and carefully review the product label's instructions. For external use only; avoid exceeding the recommended dose. Report any known allergies to this medication to your physician. Common side effects may include burning, itching, irritation, and redness at the application site. Persistent or concerning side effects warrant immediate medical attention. Disclose any existing medical conditions, including pregnancy, to your doctor before use. This ointment is considered safe for breastfeeding mothers.
Uses of Lozivate-MF XL Ointment
Atopic dermatitis and/or psoriatic disease
Major Benefits of Lozivate-MF XL Ointment:
Apply this medication topically only. Follow your physician's instructions regarding dosage and treatment length. Always consult the product label for application guidelines. Before applying, cleanse and thoroughly dry the affected skin, then gently rub in the ointment.
Common Side effects of Lozivate-MF XL Ointment:
- Application site reactions (burning, irritation, itching and redness)
How to use Lozivate-MF XL Ointment:
Apply this medication topically only. Follow your physician's instructions regarding dosage and treatment length. Always consult the product label for application details prior to use. Ensure the affected skin is clean and dry before gently rubbing in the ointment.
How Lozivate-MF XL Ointment works:
Lozivate-MF XL Ointment combines four active ingredients—clobetasol propionate, salicylic acid, lactic acid, and urea—to effectively manage eczema and psoriasis symptoms. Clobetasol propionate, a corticosteroid, reduces inflammation by inhibiting the release of inflammatory mediators like prostaglandins, thus alleviating redness, swelling, and itching. The keratolytic agents, salicylic acid, lactic acid, and urea, work synergistically to dissolve hardened skin layers, facilitating the removal of dead skin cells and improving skin suppleness. This keratolytic action also promotes enhanced penetration of clobetasol propionate into the affected skin.
SAFETY ADVICE
AlcoholNone
No known drug interactions.
PregnancyCONSULT YOUR DOCTOR
The use of Lozivate-MF XL Ointment during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to any prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Lozivate-MF ointment is likely safe for use while breastfeeding. Available human data indicates minimal risk to the infant.
DrivingNone
No known drug interactions.
KidneyNone
No known drug interactions.
LiverNone
No known drug interactions.
What if you forget to take Lozivate-MF XL Ointment :
Should you forget a Lozivate-MF XL Ointment application, use it at your earliest convenience. If, however, your next scheduled application is imminent, omit the missed one and resume your usual dosing regimen. Avoid applying a double dose.
Facts to Know About Lozivate-MF XL Ointment
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | DERMA |



